Dec 17, 2025
Gastrointestinal Combination Products: Generic Availability and Alternatives
Explore how the FDA reviews biosimilars under the new 2025 guidance. Learn about the shift from clinical trials to analytical characterization, interchangeability rules, and what this means for patient access and drug costs.